MLYS Company Profile and Key Details
Mineralys Therapeutics, Inc.
MLYS Stock Price Chart
Stock Price Today
Mineralys Therapeutics, Inc. (MLYS) stock surged +4.30%, trading at $10.19 on NASDAQ, up from the previous close of $9.77. The stock opened at $9.80, fluctuating between $9.74 and $10.43 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and associated cardiovascular diseases. It clinical-stage product candidate is lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase inhibitor for the treatment of patients with uncontrolled or resistant hypertension. The company was incorporated in 2019 and is headquartered in Radnor, Pennsylvania.
Company Information
| Employees | 28 |
| Beta | 2.46 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Mineralys Therapeutics, Inc. (NASDAQ: MLYS) stock price is $10.19 in the last trading session. During the trading session, MLYS stock reached the peak price of $10.43 while $9.74 was the lowest point it dropped to. The percentage change in MLYS stock occurred in the recent session was 4.3% while the dollar amount for the price change in MLYS stock was $0.42.
The NASDAQ listed MLYS is part of Biotechnology industry that operates in the broader Healthcare sector. Mineralys Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Jeffrey N. Fellows
Senior Vice President of Regulatory Affairs
Ms. Jessica Ibbitson
Senior Vice President of Clinical Operations
Dr. Robert McKean Ph.D.
Senior Vice President of CMC
Ms. Danielle Bradbury
Senior Vice President of Quality Assurance
Mr. Jose Breton CPA
Vice President of Fin. & Controller
Mr. Jon Congleton
Chief Executive Officer & Director
Ms. Cindy Berejikian
Executive Vice President of Operations
Mr. Adam Scott Levy
Chief Financial Officer, Chief Bus. Officer & Sec.
Dr. David Rodman M.D.
Chief Medical Officer
Dr. Brian Taylor Slingsby M.D., M.P.H., Ph.D.
Founder & Executive Chairman
MLYS's closing price is 18.77% higher than its 52-week low of $8.58 where as its distance from 52-week high of $16.91 is -39.72%.
Number of MLYS employees currently stands at 28.
Official Website of MLYS is: https://mineralystx.com
MLYS could be contacted at phone 888 378 6240 and can also be accessed through its website. MLYS operates from 150 N. Radnor Chester Rd., Radnor, PA 19087, United States.
MLYS stock volume for the day was 244.48K shares. The average number of MLYS shares traded daily for last 3 months was 224.21K.
The market value of MLYS currently stands at $507.14M with its latest stock price at $10.19 and 49.77M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com